المؤلفون: Gershenson, David M, Miller, Austin, Brady, William E, Paul, James, Carty, Karen, Rodgers, William, Millan, David, Coleman, Robert L, Moore, Kathleen N, Banerjee, Susana, Connolly, Kate, Secord, Angeles Alvarez, O'Malley, David M, Dorigo, Oliver, Gaillard, Stephanie, Gabra, Hani, Slomovitz, Brian, Hanjani, Parviz, Farley, John, Churchman, Michael, Ewing, Ailith, Hollis, Robert L, Herrington, C Simon, Huang, Helen Q, Wenzel, Lari, Gourley, Charlie

المصدر: The Lancet. 399(10324)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Rare Diseases, Clinical Research, Cancer, Clinical Trials and Supportive Activities, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Administration, Oral, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Ovarian Epithelial, Female, Humans, MAP Kinase Kinase 1, Middle Aged, Neoplasm Grading, Neoplasm Recurrence, Local, Ovarian Neoplasms, Paclitaxel, Progression-Free Survival, Pyridones, Pyrimidinones, Standard of Care, Treatment Outcome, United Kingdom, United States, Medical and Health Sciences, General & Internal Medicine, Biomedical and clinical sciences, Health sciences

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/36f1n2djTest

المؤلفون: Talhouk, Aline, George, Joshy, Wang, Chen, Budden, Timothy, Tan, Tuan Zea, Chiu, Derek S, Kommoss, Stefan, San Leong, Huei, Chen, Stephanie, Intermaggio, Maria P, Gilks, Blake, Nazeran, Tayyebeh M, Volchek, Mila, Elatre, Wafaa, Bentley, Rex C, Senz, Janine, Lum, Amy, Chow, Veronica, Sudderuddin, Hanwei, Mackenzie, Robertson, Leong, Samuel CY, Liu, Geyi, Johnson, Dustin, Chen, Billy, Group, AOCS, Alsop, Jennifer, Banerjee, Susana N, Behrens, Sabine, Bodelon, Clara, Brand, Alison H, Brinton, Louise, Carney, Michael E, Chiew, Yoke-Eng, Cushing-Haugen, Kara L, Cybulski, Cezary, Ennis, Darren, Fereday, Sian, Fortner, Renée T, García-Donas, Jesús, Gentry-Maharaj, Aleksandra, Glasspool, Rosalind, Goranova, Teodora, Greene, Casey S, Haluska, Paul, Harris, Holly R, Hendley, Joy, Hernandez, Brenda Y, Herpel, Esther, Jimenez-Linan, Mercedes, Karpinskyj, Chloe, Kaufmann, Scott H, Keeney, Gary L, Kennedy, Catherine J, Köbel, Martin, Koziak, Jennifer M, Larson, Melissa C, Lester, Jenny, Lewsley, Liz-Anne, Lissowska, Jolanta, Lubiński, Jan, Luk, Hugh, Macintyre, Geoff, Mahner, Sven, McNeish, Iain A, Menkiszak, Janusz, Nevins, Nikilyn, Osorio, Ana, Oszurek, Oleg, Palacios, José, Hinsley, Samantha, Pearce, Celeste L, Pike, Malcolm C, Piskorz, Anna M, Ray-Coquard, Isabelle, Rhenius, Valerie, Rodriguez-Antona, Cristina, Sharma, Raghwa, Sherman, Mark E, De Silva, Dilrini, Singh, Naveena, Sinn, Peter, Slamon, Dennis, Song, Honglin, Steed, Helen, Stronach, Euan A, Thompson, Pamela J, Tołoczko, Aleksandra, Trabert, Britton, Traficante, Nadia, Tseng, Chiu-Chen, Widschwendter, Martin, Wilkens, Lynne R, Winham, Stacey J, Winterhoff, Boris, Beeghly-Fadiel, Alicia, Benitez, Javier, Berchuck, Andrew, Brenton, James D, Brown, Robert, Chang-Claude, Jenny

المصدر: Clinical Cancer Research. 26(20)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Biotechnology, Rare Diseases, Clinical Research, Genetics, Ovarian Cancer, Cancer, Clinical Trials and Supportive Activities, Detection, screening and diagnosis, 4.2 Evaluation of markers and technologies, Good Health and Well Being, Aged, Algorithms, Cystadenoma, Serous, Female, Gene Expression Regulation, Neoplastic, Humans, Lymphocytes, Tumor-Infiltrating, Middle Aged, Neoplasm Grading, Neoplasm Proteins, Neoplasm, Residual, Ovarian Neoplasms, Transcriptome, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis

الوصول الحر: https://escholarship.org/uc/item/10m827h9Test

المؤلفون: Rafii, Saeed, Gourley, Charlie, Kumar, Rajiv, Geuna, Elena, Ang, Joo Ern, Rye, Tzyvia, Chen, Lee-May, Shapira-Frommer, Ronnie, Friedlander, Michael, Matulonis, Ursula, De Greve, Jacques, Oza, Amit M, Banerjee, Susana, Molife, L Rhoda, Gore, Martin E, Kaye, Stan B, Yap, Timothy A

المصدر: Oncotarget. 5

مصطلحات موضوعية: Rare Diseases, Orphan Drug, Cancer, Ovarian Cancer, Clinical Research, Genetics, Breast Cancer, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Adult, Aged, Antineoplastic Agents, BRCA1 Protein, BRCA2 Protein, Female, Germ-Line Mutation, Humans, Middle Aged, Neoplasm Grading, Neoplasm Metastasis, Neoplasm Staging, Ovarian Neoplasms, Phthalazines, Piperazines, Poly(ADP-ribose) Polymerase Inhibitors, Prognosis, Recurrence, Survival Analysis, Treatment Outcome, PARP inhibitor, olaparib, BRCA, ovarian cancer, predictive biomarkers, Oncology and Carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/0r12702fTest

المؤلفون: Monk, Bradley J, Grisham, Rachel N, Banerjee, Susana, Kalbacher, Elsa, Mirza, Mansoor Raza, Romero, Ignacio, Vuylsteke, Peter, Coleman, Robert L, Hilpert, Felix, Oza, Amit M, Westermann, Anneke, Oehler, Martin K, Pignata, Sandro, Aghajanian, Carol, Colombo, Nicoletta, Drill, Esther, Cibula, David, Moore, Kathleen N, Christy-Bittel, Janna, Del Campo, Josep M, Berger, Regina, Marth, Christian, Sehouli, Jalid, O'Malley, David M, Churruca, Cristina, Boyd, Adam P, Kristensen, Gunnar, Clamp, Andrew, Ray-Coquard, Isabelle, Vergote, Ignace

المساهمون: UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service d'oncologie médicale

المصدر: Journal of clinical oncology, Vol. 38, no.32, p. 3753-3762 (2020)

مصطلحات موضوعية: Adult, Aged, Benzimidazoles, Cystadenocarcinoma, Serous, Doxorubicin, Fallopian Tube Neoplasms, Female, Humans, MAP Kinase Kinase 1, MAP Kinase Kinase 2, Middle Aged, Neoplasm Grading, Neoplasm Recurrence, Local, Ovarian Neoplasms, Paclitaxel, Peritoneal Neoplasms, Polyethylene Glycols, Progression-Free Survival, Protein Kinase Inhibitors, Topotecan, Young Adult

العلاقة: boreal:250286; http://hdl.handle.net/2078.1/250286Test; info:pmid/32822286; urn:ISSN:0732-183X; urn:EISSN:1527-7755

الإتاحة: https://doi.org/10.1200/JCO.20.01164Test
http://hdl.handle.net/2078.1/250286Test

المؤلفون: M. Gershenson, David, Miller, Austin, E Brady, William, Paul, James, Carty, Karen, Rodgers, William, Millan, David, L Coleman, Robert, N Moore, Kathleen, Banerjee, Susana, Connolly, Kate, Alvarez Secord, Angeles, M O'Malley, David, Dorigo, Oliver, Gaillard, Stephanie, Gabra, Hani, Slomovitz, Brian, Hanjani, Parviz, Farley, John, Churchman, Michael, Ewing, Ailith, Hollis, Robb, Herrington, C Simon, Q Huang, Helen, B Wenzel, Lari, Gourley, Charlie

المصدر: M. Gershenson, D, Miller, A, E Brady, W, Paul, J, Carty, K, Rodgers, W, Millan, D, L Coleman, R, N Moore, K, Banerjee, S, Connolly, K, Alvarez Secord, A, M O'Malley, D, Dorigo, O, Gaillard, S, Gabra, H, Slomovitz, B, Hanjani, P, Farley, J, Churchman, M, Ewing, A, Hollis, R, Herrington, C S, Q Huang, H, B Wenzel, L & Gourley, C 2022, ' Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): a randomised, open-label phase 2/3 trial ', The Lancet, vol. 399, no. 10324, pp. 541-553 . https://doi.org/10.1016/S0140-6736Test(21)02175-9

مصطلحات موضوعية: Adult, Pyridones/administration & dosage, Administration, Oral, Ovarian Neoplasms/drug therapy, Standard of Care, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, Progression-Free Survival, United Kingdom, United States, Treatment Outcome, Paclitaxel/administration & dosage, Humans, Female, MAP Kinase Kinase 1/metabolism, Pyrimidinones/administration & dosage, Neoplasm Grading, Neoplasm Recurrence, Local/pathology, Aged, Carcinoma, Ovarian Epithelial/drug therapy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______3094::10daf3830e8817199b8469c4d2ece72cTest
https://hdl.handle.net/20.500.11820/745251c7-7e6d-4cf1-9129-3a76f1637764Test

المؤلفون: Gershenson, DM, Miller, A, Brady, WE, Paul, J, Carty, K, Rodgers, W, Millan, D, Coleman, RL, Moore, KN, Banerjee, S, Connolly, K, Secord, AA, O'Malley, DM, Dorigo, O, Gaillard, S, Gabra, H, Slomovitz, B, Hanjani, P, Farley, J, Churchman, M, Ewing, A, Hollis, RL, Herrington, CS, Huang, HQ, Wenzel, L, Gourley, C

المساهمون: Banerjee, Susana

مصطلحات موضوعية: Administration, Oral, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Ovarian Epithelial, Female, Humans, MAP Kinase Kinase 1, Middle Aged, Neoplasm Grading, Neoplasm Recurrence, Local, Ovarian Neoplasms, Paclitaxel, Progression-Free Survival, Pyridones, Pyrimidinones, Standard of Care, Treatment Outcome, United Kingdom, United States

جغرافية الموضوع: England

وصف الملف: Print; 553; application/pdf

العلاقة: S0140-6736(21)02175-9; The Lancet, 2022, 399 (10324), pp. 541 - 553; https://repository.icr.ac.uk/handle/internal/5220Test

الإتاحة: https://doi.org/10.1016/S0140-6736Test(21)02175-9
https://repository.icr.ac.uk/handle/internal/5220Test

المؤلفون: George, A, McLachlan, J, Tunariu, N, Della Pepa, C, Migali, C, Gore, M, Kaye, S, Banerjee, S

المساهمون: Gore, Martin, Banerjee, Susana, Tunariu, Nina, Marsden, Kaye, Stanley Bernard

مصطلحات موضوعية: Humans, Carcinoma, Ovarian Neoplasms, Recurrence, Tamoxifen, Nitriles, Triazoles, Receptors, Estrogen, Antineoplastic Agents, Hormonal, Neoplasm Staging, Treatment Outcome, Retreatment, Retrospective Studies, Adult, Aged, 80 and over, Middle Aged, Female, Young Adult, Neoplasm Grading, Biomarkers, Tumor, Letrozole

وصف الملف: Electronic; ?; image/png

العلاقة: BMC cancer, 2017, 17 (1), pp. 456 - ?; https://repository.icr.ac.uk/handle/internal/1259Test

الإتاحة: https://doi.org/10.1186/s12885-017-3440-0Test
https://repository.icr.ac.uk/handle/internal/1259Test

المؤلفون: Rafii, S, Gourley, C, Kumar, R, Geuna, E, Ern Ang, J, Rye, T, Chen, L-M, Shapira-Frommer, R, Friedlander, M, Matulonis, U, De Greve, J, Oza, AM, Banerjee, S, Molife, LR, Gore, ME, Kaye, SB, Yap, TA

المساهمون: Yap, Timothy, Gore, Martin, Banerjee, Susana, Molife, Rhoda, Marsden, Kaye, Stanley Bernard

مصطلحات موضوعية: Humans, Ovarian Neoplasms, Neoplasm Metastasis, Recurrence, Piperazines, Phthalazines, BRCA1 Protein, BRCA2 Protein, Antineoplastic Agents, Neoplasm Staging, Prognosis, Treatment Outcome, Survival Analysis, Germ-Line Mutation, Adult, Aged, Middle Aged, Female, Neoplasm Grading, Poly(ADP-ribose) Polymerase Inhibitors

وصف الملف: Print; 47160; application/pdf

العلاقة: Oncotarget, 2017, 8 (29), pp. 47154 - 47160; https://repository.icr.ac.uk/handle/internal/665Test

الإتاحة: https://doi.org/10.18632/oncotarget.17005Test
https://repository.icr.ac.uk/handle/internal/665Test